TITLE

Advances in Stem Cell Transplants May Broaden Potential for Organ Transplants/Treatments of Genetic Diseases

PUB. DATE
December 2002
SOURCE
Drug Discovery & Development;Dec2002, Vol. 5 Issue 11, p21
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Reports on the impact of advances in stem cell transplant research on the potentials for treating genetic diseases. Production of healthy transplanted stem cells in mice; Reduction of hazardous side effects of cell and organ transplants on the host.
ACCESSION #
8733586

Tags: STEM cells -- Transplantation;  GENETIC disorders -- Treatment;  TRANSPLANTATION of organs, tissues, etc. -- Complications

 

Related Articles

  • Value of Pretransplant Pulmonary Function Tests in Predicting Pulmonary Complications After Autologous Peripheral Stem Cell Transplantation. El-Khatib, Mohamad; Bou-Khalil, Pierre; Abbas, Ossama; Salman, Ali; Jamaleddine, Ghassan // Lung;Dec2007, Vol. 185 Issue 6, p321 

    The aim of this study was to evaluate the value of pulmonary function tests performed before an autologous peripheral stem cell transplant (APSCT) in identifying patients who are at risk for developing post-transplant pulmonary complications. This retrospective study included patients who...

  • Immune Reconstitution and Clearance of Human Adenovirus Viremia in Pediatric Stem-Cell Recipients. Heemskerk, Bianca; Lankester, Arjan C.; van Vreeswijk, Tamara; Beersma, Matthias F. C.; Claas, Eric C. J.; Veltrop-Duits, Louise A.; Kroes, Aloys C. M.; Vossen, Jaak M. J. J.; Schilham, Marco W.; van Tol, Maarten J. D. // Journal of Infectious Diseases;2/15/2005, Vol. 191 Issue 4, p520 

    Background. Human adenovirus (HAdV) infections are increasingly frequent complications of allogeneic stem-cell transplantation (SCT), especially in children. Only a few data on the correlation between immune recovery and the course of HAdV infection are available, and data on HAdV-specific...

  • Transplantation of haploidentically mismatched stem cells for the treatment of malignant diseases. Aversa, Franco; Martelli, Massimo // Springer Seminars in Immunopathology;Sep2004, Vol. 26 Issue 1/2, p155 

    Hematopoietic stem cell transplantation (HSCT) from HLA haploidentical mismatched donors has recently been developed for patients with high-risk acute leukemia who do not have a matched donor. After a high intensity conditioning regimen the HLA barrier is overcome by infusing a graft containing...

  • Ischemic cardiomyopathy. Betigeri, A. M.; Guhathakurta, Soma; Cherian, K. M. // Internet Journal of Cardiovascular Research;2009, Vol. 6 Issue 1, p3 

    The term "regenerative medicine" is a multidisciplinary field involving molecular and cell biologist, embryologist, pathologist, clinicians, bioengineers, and not to exclude ethicists. Early clinical studies, so for have indicate that, a stem cell implantation is feasible and has beneficial...

  • Rhizomucor and Scedosporium Infection Post Hematopoietic Stem-Cell Transplant. Marques, D�nia Sofia; Vaz, Carlos Pinho; Branca, Rosa; Campilho, Fernando; Lamelas, Catarina; Afonso, Luis Pedro; Jacome, Manuel; Breda, Eduardo; Monteiro, Eurico; J�nior, Ant�nio Campos // Case Reports in Medicine;2011, p1 

    Hematopoietic stem-cell transplant recipients are at increased risk of developing invasive fungal infections. This is a major cause of morbidity and mortality. We report a case of a 17-year-old male patient diagnosed with severe idiopathic acquired aplastic anemia who developed fungal...

  • Late hemorrhagic cystitis after reduced-intensity hematopoietic stem cell transplantation (RIST). Yamamoto, R.; Kusumi, E.; Kami, M.; Yuji, K.; Hamaki, T.; Saito, A.; Murasgihe, N.; Hori, A.; Kim, S.-W.; Makimoto, A.; Ueyama, J.; Tanosaki, R.; Miyakoshi, S.; Mori, S.; Morinaga, S.; Heike, Y.; Taniguchi, S.; Masuo, S.; Takaue, Y.; Mutou, Y. // Bone Marrow Transplantation;Dec2003, Vol. 32 Issue 11, p1089 

    Summary:We reviewed medical records of 256 patients to investigate the frequency and characteristics of hemorrhagic cystitis (HC) associated with reduced-intensity stem cell transplantation (RIST) as opposed to conventional stem cell transplantation (CST); 137 patients underwent CST and 119...

  • Failure of trilineage blood cell reconstitution after initial neutrophil engraftment in patients undergoing allogeneic hematopoietic cell transplantation - frequency and outcomes. J-H Lee, L.; S-J Choi, L.; J-H Lee, L.; Y-S Lee, L.; W-K Kim, L.; J-S Lee, L.; K-H Lee, L.; S. Kim; M. Seol, L. // Bone Marrow Transplantation;Apr2004, Vol. 33 Issue 7, p729 

    Summary:The outcomes of patients who experience the failure to reconstitute a trilineage of blood cells after initial neutrophil engraftment were evaluated in 178 patients with hematologic disorders, who underwent allogeneic HCT. Of 165 qualified patients (five with primary engraftment failure;...

  • Implications of early airflow decline after myeloablative allogeneic stem cell transplantation. Martin, P. J.; Flowers, M. E.; Nichols, W. G.; Clark, J. G.; Chien, J. W. // Bone Marrow Transplantation;Apr2004, Vol. 33 Issue 7, p759 

    Summary:The clinical significance of early airflow decline after myeloablative allogeneic hematopoietic SCT is uncertain. We performed a retrospective cohort analysis to determine if airflow decline by day 100 is associated with later development of transplant-related airflow obstruction (AFO)...

  • Risk factors for post-engraftment invasive aspergillosis in allogeneic stem cell transplantation. Thursky, K; Byrnes, G; Grigg, A; Szer, J; Slavin, M // Bone Marrow Transplantation;Jul2004, Vol. 34 Issue 2, p115 

    Summary:The majority of invasive aspergillosis (IA) in allogeneic stem cell transplantation (SCT) occurs during the post-engraftment period. We used Cox proportional hazards regression to evaluate post-engraftment IA risk in a cohort of 217 allogeneic SCT recipients from 1991 to 1998. The aim...

Share

Read the Article

Courtesy of your local library

Public Libraries Near You (See All)
Looking for a Different Library?

Other Topics